George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 527.80
Bid: 526.40
Ask: 527.20
Change: 9.60 (1.85%)
Spread: 0.80 (0.152%)
Open: 522.60
High: 527.80
Low: 511.40
Prev. Close: 518.20
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Voting Results

29 Jul 2022 10:28

RNS Number : 2590U
B&M European Value Retail S.A.
29 July 2022
 

 

 

29 July 2022

B&M European Value Retail S.A.

 

 

AGM Voting Results

 

 

All resolutions proposed at the Annual General Meeting of the Company held on 28 July 2022 were passed on a poll by shareholders. The results of the poll were as follows.

 

VOTES

FOR

%

VOTES

AGAINST

%

VOTES

TOTAL

% of ISC

VOTED

VOTES WITHHELD

1

To receive the Directors Report on the Annual Accounts of the Company for the year ended March 2022

 

690,135,303

99.8

1,613,795

0.2

691,749,098

69.09

1,769,229

2

To receive the consolidated and unconsolidated Financial Statements and Annual Accounts for the financial year ended March 2022 and the Auditor's Reports thereon

 

690,135,303

99.8

1,613,795

0.2

691,749,098

69.09

1,769,229

3

To approve the consolidated Financial Statements and Annual Accounts of the Company for the year ended 26 March 2022

690,135,303

99.8

1,613,795

0.2

691,749,098

69.09

1,769,229

4

To approve the unconsolidated Financial Statements and Annual Accounts of the Company for the year ended 31 March 2022

 

690,134,972

99.8

1,614,126

0.2

691,749,098

69.09

1,769,229

5

To approve the result of the Company for the year ended 31 March 2022 and allocation

 

692,447,944

100

0

0.0

692,447,944

69.16

1,070,383

6

To approve the total dividend of the Company for the year ended 31 March 2022

 

692,448,944

100

0

0.0

692,448,944

69.16

1,069,383

7

 

To receive and approve the annual report on the Directors' Remuneration

 

637,198,382

94.3

38,312,060

5.7

675,510,442

67.47

18,007,885

8

To discharge each of the Directors for the financial year ended 31 March 2022

 

687,806,873

99.5

3,355,234

0.5

691,062,107

69.03

2,356,220

9

To re-elect Peter Bamford as a Director

 

660,170,568

95.3

32,277,376

4.7

692,447,944

69.16

1,070,383

10

To re-elect Simon Arora as a Director

 

671,929,416

97.0

20,518,528

3.0

692,447,944

69.16

1,070,383

11

To re-elect Alejandro Russo as a Director

 

689,686,373

99.6

2,760,947

0.4

692,447,320

69.16

1,071,007

12

To re-elect Ron McMillan as a Director

 

584,930,361

86.5

91,350,493

13.5

676,280,854

67.55

17,237,473

13

To re-elect Tiffany Hall as a Director

 

638,580,013

92.2

53,867,207

7.8

692,447,220

69.16

1,071,107

14

To re-elect Carolyn Bradley as a Director

667,183,563

96.4

25,263,757

3.6

692,447,320

69.16

1,071,007

15

To re-elect Paula MacKenzie as a Director

692,096,400

99.9

351,544

0.1

692,447,944

69.16

1,070,383

16

To discharge the Independent Auditor for the year ended 31 March 2022

 

688,545,309

99.6

2,617,422

0.4

691,162,731

69.03

2,355,596

17

To re-appoint KPMG Luxembourg Société Coopérative as Independent Auditor of the Company

 

677,254,487

98.0

13,579,622

2.0

690,834,149

68.99

2,684,178

18

 

 

 

To authorise the Directors to determine the Independent Auditor's remuneration

678,868,282

98.0

13,579,622

2.0

692,447,944

69.16

1,070,383

19

To authorise the Company to make market purchases of its ordinary shares of up to 10% of its ordinary issued shares *

 

688,778,366

99.5

3,338,993

0.5

692,117,359

69.13

1,400,968

20

To confirm the Board of Directors have full power to issue ordinary shares on a non-pre-emptive basis for cash representing 5% of the issued share capital of the Company generally, as provided by the Articles of Association and to acknowledge the Directors' intention to comply with the Statement of Principles on Dis-applying Pre-Emption Rights to the extent practical for a Luxembourg company

 

692,296,618

99.98

152,326

0.02

692,448,944

69.16

1,069,383

21

To confirm the Board of Directors have full power, in addition to any authority granted under resolution 20, to issue ordinary shares on a non-pre-emptive basis, for cash representing a further 5% of the issued share capital of the Company for the purposes of financing an acquisition or a capital investment (or refinancing such a transaction) as defined in the Statement of Principles on Dis-Applying Pre-Emption Rights, as provided by the Articles of Association

 

690,606,503

99.7

1,781,172

0.3

692,387,675

69.15

1,130,652

 

* Whilst the Company seeks authority on an annual basis to perform share buybacks (as is customary for UK PLCs), the Board notes that it has no current intention of utilising this authority, reflecting the complexities of executing an on market buyback for a company incorporated in Luxembourg such as B&M. The Board continuously reviews the Group's capital structure and has regularly returned funds to all its shareholders by way of both ordinary and special dividends.

 

 

The results of the poll will also be posted on the Company's website at www.bandmretail.com

 

Please note that a vote withheld is not a vote in law and is not counted in the calculation of votes for and against a resolution.

 

The total number of shares of the Company in issue on the record date on 14 July 2022 (for being eligible to vote at the AGM) was 1,001,226,836 ordinary shares.

 

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive Officer

Alejandro Russo, Chief Financial Officer

Investor.relations@bandmretail.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMRLMLTMTTTMJT
Date   Source Headline
24th Apr 20249:00 amRNSNotice of Ordinary General Meeting
16th Apr 20247:00 amRNSFY24 Post Close Trading Statement
4th Apr 202410:00 amRNSNotice of FY24 Post Close Trading Statement
22nd Mar 20249:00 amRNSBoard Appointment
8th Feb 20249:00 amRNSConfirmation of timing of FY24 Preliminary Results
1st Feb 20241:00 pmRNSMajor Shareholding in Company TR-1
30th Jan 20246:23 pmRNSHolding(s) in Company
24th Jan 202410:00 amRNSPDMR Purchase of Shares
23rd Jan 202412:00 pmRNSB&M Plans Chairman Succession
18th Jan 20242:46 pmRNSNotification of Major Shareholding
15th Jan 20242:20 pmRNSBlock listing Interim Review
9th Jan 20247:00 amRNSGolden Quarter - strong profitable growth
22nd Dec 202312:00 pmRNSCorrection: PDMR announcement
22nd Dec 20238:30 amRNSPost Stabilisation Notice
19th Dec 20239:04 amRNSPCA Notification
15th Dec 20239:00 amRNSNotification of major holdings
13th Dec 202312:10 pmRNSAnnouncement further to recent placing by SSA
30th Nov 20235:41 pmRNSChange of Registered Office
30th Nov 20234:01 pmRNSTotal Voting Rights
28th Nov 20239:22 amRNSDirector/PDMR Shareholding
27th Nov 20235:13 pmRNSNotice of FY24 Third Quarter Trading Statement
24th Nov 202310:35 amRNSPDMR Notification
21st Nov 202311:32 amRNSFinal Results of Tender Offer 3.625% Senior Notes
15th Nov 202310:11 amRNSTender Offer Indicative Maximum Acceptance Amount
14th Nov 20235:52 pmRNSPricing of £250 Million Senior Secured Notes
13th Nov 20232:28 pmRNSPre Stabilisation Notice
13th Nov 20239:39 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:30 amRNSTender Offer
13th Nov 20239:27 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:07 amRNS£250 Million Senior Secured Notes Offering
9th Nov 20237:00 amRNSFY24 Interim Results
3rd Oct 20237:25 amRNSTotal Voting Rights
22nd Sep 202311:33 amRNSDirector Appointment and Results of OGM
19th Sep 20238:50 amRNSTiming of announcement of Half Year Results
7th Sep 20232:19 pmRNSNotification of major holdings
7th Sep 20231:31 pmRNSDirector/PDMR Shareholding
5th Sep 20239:48 amRNSAcquisition of Assets from Wilko Ltd (in admin)
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Aug 20239:08 amRNSNotice of Ordinary General Meeting- replace
14th Aug 20237:00 amRNSNotice of Ordinary General Meeting
9th Aug 20234:02 pmRNSGrant of share options to PDMR
2nd Aug 20239:21 amRNSGrant of options to senior managers
2nd Aug 20239:18 amRNSGrant of options to Directors
28th Jul 20237:00 amRNSGroup Trading Director Retention Agreement
27th Jul 20231:42 pmRNSTR-1 Correction Announcement
26th Jul 20234:15 pmRNSTR-1 Notification of major holdings
26th Jul 20233:33 pmRNSBoard change
26th Jul 20238:45 amRNSEGM Voting results announcement
26th Jul 20238:15 amRNSAGM 2023 Voting results announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.